Why the study?
The study investigated the impact of therapeutic interventions on red blood cell deformability and microscale transport, using statins as an exemplar.
Do statins alter the deformability and microscale transport dynamics of human red blood cells in vitro?
Do statins alter the deformability and microscale transport dynamics of human red blood cells in vitro?
Answers are grounded in this paper and cite their sources.
In vitro statin treatment enhances red blood cell deformability and alters microscale transport dynamics, suggesting a potential mechanism for their microvascular effects.
The impact of therapeutic interventions on red blood cell (RBC) deformability and microscale transport is investigated, using statins as an exemplar. Human RBCs were treated in vitro with two commonly prescribed statins, atorvastatin and rosuvastatin, at clinically relevant concentrations. Changes in RBC deformability were quantified using a microfluidic-based ektacytometer and expressed in terms of the elongation index. Dilute suspensions of the statin-treated RBCs were then perfused through a microfluidic pillar array, at a constant flow rate and negligible inertia, and imaged. Particle Tracking Velocimetry (PTV) was applied to track RBCs, identify preferential paths and estimate their velocities, whereas image processing was used to estimate cell dynamics, perfusion metrics and distributions. The findings were compared against those of healthy, untreated cells. Statins enhanced RBC deformability in agreement with literature. The extent of enhancement was found to be statin-dependent. The softer statin-treated cells were found to flow in straight, less tortuous paths, spend more time inside the pillar array and exhibit lower velocities compared to healthy RBCs, attributed to their enhanced deformation and longer shape recovery time upon impact with the array posts. The in vitro microfluidic approach demonstrated here may serve as a monitoring tool to personalise and maximise the outcome of a therapeutic treatment. • Red blood cells treated with statins exhibit enhanced deformability. • The deformability enhancement is statin dependent. • Enhanced deformation alters perfusion through a micropillar array. • Statin treated RBCs follow less tortuous paths and spend more time in the array. • They collide more with the pillars and take longer to recover their shape.
No takes yet. Share an insight, caveat, or question.
Stathoulopoulos et al. (2024) studied Healthy human red blood cells (in vitro). Atorvastatin and Rosuvastatin vs. Untreated healthy RBCs was evaluated on Maximum elongation index (EImax) (p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: